UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations

Annals of oncology, 2015-02, Vol.26 (2), p.288-300

2015

Volltextzugriff (PDF)

Prostate-specific antigen kinetics as a surrogate endpoint in clinical trials of metastatic castration-resistant prostate cancer: A review

Cancer treatment reviews, 2012-12, Vol.38 (8), p.1020-1026

Colloca, G

2012

Volltextzugriff (PDF)

Neutropenia in metastatic colorectal cancer receiving trifluridine/tipiracil

Annals of oncology, 2020-07, Vol.31 (7), p.958-958

2020

Volltextzugriff (PDF)

Different variables predict the outcome of patients with synchronous versus metachronous metastases of colorectal cancer

Clinical & translational oncology, 2020-08, Vol.22 (8), p.1399-1406

2020

Volltextzugriff (PDF)

Trial-level analysis of early tumor shrinkage and disease control rate as intermediate end points of first-line medical treatment in randomized studies of metastatic colorectal cancer

Annals of oncology, 2018-06, Vol.29, p.v74-v74

2018

Volltextzugriff (PDF)

Treating cancer and no-cancer pain in older and oldest old patients

Current pharmaceutical design, 2015-01, Vol.21 (13), p.1706-1714

2015

Volltextzugriff (PDF)

Treating cancer in older and oldest old patients

Current pharmaceutical design, 2015-01, Vol.21 (13), p.1699-1705

2015

Volltextzugriff (PDF)

P-193 Tumor burden-related variables in trials of metastatic colorectal cancer

Annals of oncology, 2023-06, Vol.34, p.S84-S84

2023

Volltextzugriff (PDF)

P-86 Hypo-albuminemia as a tumor-related prognostic factor in metastatic pancreatic adenocarcinoma

Annals of oncology, 2023-06, Vol.34, p.S44-S44

2023

Volltextzugriff (PDF)

Analysis of Clinical End Points of Randomised Trials Including Bevacizumab and Chemotherapy versus Chemotherapy as First-line Treatment of Metastatic Colorectal Cancer

Clinical oncology (Royal College of Radiologists (Great Britain)), 2016-10, Vol.28 (10), p.e155-e164

2016

Volltextzugriff (PDF)

Frailty screening in dermato‐oncology practice: a modified Delphi study and a systematic review of the literature

Journal of the European Academy of Dermatology and Venereology, 2021-01, Vol.35 (1), p.95-104

2021

Volltextzugriff (PDF)

P-203 Relationship of myelotoxicity and of gastrointestinal toxicity with the treatment outcome in trials of second-line chemotherapy of patients with metastatic colorectal cancer

Annals of oncology, 2021-07, Vol.32, p.S169

2021

Volltextzugriff (PDF)

P-204 Survival improvement from the addition of biologics is not affected by performance status in patients with metastatic colorectal cancer: A meta-analysis

Annals of oncology, 2021-07, Vol.32, p.S169

2021

Volltextzugriff (PDF)

CA125-related tumor cell kinetics variables after chemotherapy in advanced ovarian cancer: a systematic review

Clinical & translational oncology, 2016-08, Vol.18 (8), p.813-824

2016

Volltextzugriff (PDF)

Prevalence of the seven cardiovascular health metrics in a Mediterranean country: results from a cross-sectional study

European journal of public health, 2013-10, Vol.23 (5), p.858-862

2013

Volltextzugriff (PDF)

SARCOPENIA IS AN INDEPENDENT PROGNOSTIC FACTOR IN ELDERLY MALE PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA: RESULTS FROM A MULTICENTER EXPERIENCE

Hematological oncology, 2021-06, Vol.39 (S2)

2021

Volltextzugriff (PDF)

SP-0253 COMPREHENSIVE ASSESSMENT IN ELDERLY PATIENTS WITH CANCER

Radiotherapy and oncology, 2012-05, Vol.103, p.S100-S101

2012

Volltextzugriff (PDF)

Erythropoiesis-stimulating agents (ESAs), from chemotherapy-induced anemia to any cancer-related anemia?

Annals of oncology, 2010-04, Vol.21 (4), p.905-906

2010

Volltextzugriff (PDF)

About sorafenib in castration-resistant prostate cancer

Annals of oncology, 2008-10, Vol.19 (10), p.1812-1813

2008

Volltextzugriff (PDF)

P-262Trial-level analysis of early tumor shrinkage and disease control rate as intermediate end points of first-line medical treatment in randomized studies of metastatic colorectal cancer

Annals of oncology, 2018-06, Vol.29 (suppl_5)

2018

Volltextzugriff (PDF)

Same patient in different European countries: Assessment and management pressure ulcers in Italy

European geriatric medicine, 2011-12, Vol.2 (6), p.378-379

2011

Volltextzugriff (PDF)

Age is not a negative prognostic factor for the outcome of leukemic patients receiving treatment in an intensive care unit (ICU)

Critical reviews in oncology/hematology, 2008-10, Vol.68, p.S50-S50

2008

Volltextzugriff (PDF)

P26 A multidisciplinary onco-geriatric approach for the management of older patients with gynaecological cancer

Critical reviews in oncology/hematology, 2009, Vol.72 (1), p.S28-S28

2009

Volltextzugriff (PDF)

P96 The impact of chemotherapy on body composition and functional status in elderly cancer patients

Critical reviews in oncology/hematology, 2009, Vol.72 (1), p.S52-S53

2009

Volltextzugriff (PDF)

1 – 25 von 170

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(157)
Mit Volltextzugriff
(135)

Publikationsform

Sprache

Englisch
(168)
Italienisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Screening tools for multidimensional health problems warranting a geriatric assessment in older cancer patients: an update on SIOG recommendations

Prostate-specific antigen kinetics as a surrogate endpoint in clinical trials of metastatic castration-resistant prostate cancer: A review

Neutropenia in metastatic colorectal cancer receiving trifluridine/tipiracil

Different variables predict the outcome of patients with synchronous versus metachronous metastases of colorectal cancer

Trial-level analysis of early tumor shrinkage and disease control rate as intermediate end points of first-line medical treatment in randomized studies of metastatic colorectal cancer

Treating cancer and no-cancer pain in older and oldest old patients

Treating cancer in older and oldest old patients

P-193 Tumor burden-related variables in trials of metastatic colorectal cancer

P-86 Hypo-albuminemia as a tumor-related prognostic factor in metastatic pancreatic adenocarcinoma

Analysis of Clinical End Points of Randomised Trials Including Bevacizumab and Chemotherapy versus Chemotherapy as First-line Treatment of Metastatic Colorectal Cancer

Frailty screening in dermato‐oncology practice: a modified Delphi study and a systematic review of the literature

P-203 Relationship of myelotoxicity and of gastrointestinal toxicity with the treatment outcome in trials of second-line chemotherapy of patients with metastatic colorectal cancer

P-204 Survival improvement from the addition of biologics is not affected by performance status in patients with metastatic colorectal cancer: A meta-analysis

CA125-related tumor cell kinetics variables after chemotherapy in advanced ovarian cancer: a systematic review

Prevalence of the seven cardiovascular health metrics in a Mediterranean country: results from a cross-sectional study

SARCOPENIA IS AN INDEPENDENT PROGNOSTIC FACTOR IN ELDERLY MALE PATIENTS WITH CLASSICAL HODGKIN LYMPHOMA: RESULTS FROM A MULTICENTER EXPERIENCE

SP-0253 COMPREHENSIVE ASSESSMENT IN ELDERLY PATIENTS WITH CANCER

Erythropoiesis-stimulating agents (ESAs), from chemotherapy-induced anemia to any cancer-related anemia?

About sorafenib in castration-resistant prostate cancer

P-262Trial-level analysis of early tumor shrinkage and disease control rate as intermediate end points of first-line medical treatment in randomized studies of metastatic colorectal cancer

Same patient in different European countries: Assessment and management pressure ulcers in Italy

Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group

Age is not a negative prognostic factor for the outcome of leukemic patients receiving treatment in an intensive care unit (ICU)

P26 A multidisciplinary onco-geriatric approach for the management of older patients with gynaecological cancer

P96 The impact of chemotherapy on body composition and functional status in elderly cancer patients

Suchergebnisse filtern